[Detection of ABL kinase domain point mutations in chronic myeloid leukemia patients receiving imatinib treatment]. [electronic resource]
Producer: 20090413Description: 704-6 p. digitalISSN:- 1673-4254
- Antineoplastic Agents -- therapeutic use
- Base Sequence
- Benzamides
- Drug Resistance -- genetics
- Female
- Humans
- Imatinib Mesylate
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Male
- Molecular Sequence Data
- Piperazines -- therapeutic use
- Point Mutation
- Protein-Tyrosine Kinases -- genetics
- Pyrimidines -- therapeutic use
No physical items for this record
Publication Type: English Abstract; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.